Topiramate Treatment of Essential Tremor in a Patient with Cognitive Deficits
- PMID: 20689627
- PMCID: PMC2914364
- DOI: 10.1159/000264609
Topiramate Treatment of Essential Tremor in a Patient with Cognitive Deficits
Abstract
This case report demonstrates a satisfying response to topiramate in a 79-year-old patient with disabling essential tremor in whom propranolol as well as primidone had to be discontinued due to severe side effects. After 28 months of topiramate treatment, a clear decline in Mini Mental State Examination (MMSE) could be observed, stressing the use of care in prescribing topiramate in elderly patients.
Figures
References
-
- Louis ED, Ottmann R, Hauser WA. How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world. Mov Disord. 1998;13:5–10. - PubMed
-
- Ondo WG, Jankovic J, Connor GS, Pahwa R, et al. Topiramate in essential tremor. Neurology. 2006;66:672–677. - PubMed
-
- Koller WC, Vetere-Overfield B. Acute and chronic effects of propanolol and primidone in essential tremor. Neurology. 1989;39:1587–1588. - PubMed
-
- Hansten PD, Horn JR. St. Louis: Facts and comparisons. In: Wickersham RM, O'Dell JA, editors. Managing Clinically Important Drug Interactions. Amsterdam: Wolters Kluwer; 2004.
-
- Gatto EN, Ruca MC, Raina G, Micheli F. Low doses of topiramate are effective in essential tremor, a report of three cases. Clin Neuropharmacol. 2003;26:294–296. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
